HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 118 filers reported holding HORIZON PHARMA PLC in Q3 2014. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,584,000 | +53.3% | 132,216 | +53.6% | 0.05% | +21.4% |
| Q3 2018 | $1,686,000 | -13.7% | 86,091 | -37.4% | 0.04% | -33.3% |
| Q1 2018 | $1,954,000 | +38.6% | 137,592 | +42.5% | 0.06% | +75.0% |
| Q4 2017 | $1,410,000 | +332.5% | 96,558 | +275.9% | 0.04% | +350.0% |
| Q3 2017 | $326,000 | +9.8% | 25,688 | +27.8% | 0.01% | -11.1% |
| Q1 2017 | $297,000 | -82.4% | 20,100 | -80.7% | 0.01% | -79.1% |
| Q4 2016 | $1,684,000 | +87.3% | 104,075 | +109.8% | 0.04% | +104.8% |
| Q3 2016 | $899,000 | -25.6% | 49,605 | -32.0% | 0.02% | -32.3% |
| Q1 2016 | $1,209,000 | +14.8% | 72,983 | +50.3% | 0.03% | +3.3% |
| Q4 2015 | $1,053,000 | +340.6% | 48,570 | +303.5% | 0.03% | +275.0% |
| Q3 2015 | $239,000 | -95.0% | 12,038 | -91.2% | 0.01% | -94.2% |
| Q2 2015 | $4,773,000 | +303.8% | 137,400 | +201.9% | 0.14% | +265.8% |
| Q1 2015 | $1,182,000 | -66.6% | 45,508 | -83.4% | 0.04% | -69.1% |
| Q4 2014 | $3,539,000 | -2.2% | 274,577 | -6.9% | 0.12% | -6.1% |
| Q3 2014 | $3,620,000 | – | 294,814 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |